Expression of cathepsin D in transitional cell bladder tumours

Journal of Pathology

Volumn 178, Issue 1, 1996, Pages 59-64

  Lipponen, Pertti K ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Bladder tumours; Cathepsin D; Umbrella cells

Indexed keywords

CATHEPSIN D; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ARTICLE; BLADDER CARCINOMA; CANCER INVASION; CELL CYCLE S PHASE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CATHEPSIN D; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0030055803     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199601)178:1<59::AID-PATH418>3.0.CO;2-E     Document Type: Article

References (34)

1. Liotta LA. Tumour invasion and metastases-role of basement membrane Am J Pathol 1984; 117: 339-347.
2. Lipponen P The prognostic value of basement membrane morphology, tumour histology and morphometry in superficial bladder cancer J Cancer Res Clin Oncol 1993; 119: 295-300.
3. Schapers RFM, Pauwels RPE, Havenith MG, Smeets AWGB, Brandt PA van der. Bosman FT. Prognostic significance of type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder. Cancer 1990; 66: 2583-2588.
4. Daher N, Abourachid H, Bove N, Petit J, Burtin P. Collagen IV staining pattern in bladder carcinomas, relationship to prognosis Br J Cancer 1987; 55: 665-671.
5. Redwood SM, Liu BC, Weiss RE, Hodge DE, Droller MJ Abrogation of the invasion of human bladder tumour cells by using protease inhibitor(s) Cancer 1992; 69: 1212-1219
6. Morrisset M, Capony F, Rocherford H. The 52 kDa estrogen induced protein secreted by MCF-7 cells is a lysosomal acidic protease. Biochem Biophys Res Commun 1986, 138: 102-109.
7. Westley B, Rochefort H. A secreted glycoprotein induced by estrogen in human breast cancer cell lines Cell 1980, 20: 352-362.
8. Vignon F, Capony F, Chambon M, et al Autocrine growth stimulation of the MCF-7 breast cancer cells by the estrogen-resulated 52 K protein Endocrinology 1986, 118: 1537-1545
9. r 52,000 cathepsin D secreted by breast cancer cells Cancer Res 1988, 48: 3688-3692.
10. Tan PE, Benz CC, Dollbaum C, et al. Prognostic value of cathepsin D expression in breast cancer immunohistochemical assessment and correlation with radiometric assay. Ann Oncol 1994, 5: 329-336.
11. Domagdala W, Striker G, Szadowska A, Dukowicz A, Weber K, Osborn M. Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry No correlation with survival at 5 years Am J Pathol 1992, 141: 1003-1012
12. Isola J, Weitz S, Visakorpi T, et al. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer J Clin Oncol 1993; 11: 36-43
13. Rio MC, Bellocq JP, Daniel JY, et al Breast cancer associated pS2 protein; synthesis and secretion by normal stomach mucosa. Science 1988; 241: 705-708
14. Rochefort H, Cavailles V, Augereau P, et al. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancel. J Steroid Biochem 1989; 34: 177-182
15. Zingg EJ, Wallace DMA. Bladder Cancer. Heidelberg: Sprinaer-Verlag, 1985: 1-21, 161 191.
16. UICC. International Union Against Cancer. TNM Classification of Malignant Tumours. Geneva: UICC, 1978.
17. Mostofi FK. International histological classification of tumours In No 10 Histological Typing of Urinary Bladder Tumours Geneva: WHO, 1973.
18. Lipponen PK, Eskelinen MJ, Jauhiainen K, Harju E, Terho R. Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. Eur J Cancer 1993, 29A: 69-75.
19. Lipponen PK, Nordling S, Eskelinen MJ, Jauhiainen K, Terho R, Harju E Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer. Int J Cancer 1993; 53: 42-47.
20. Lipponen PK, Eskelinen MJ, Jauhiainen K, Harju E, Terho R, Haapasalo H. Independent clinical, histological and quantitative prognostic factors in transitional-cell bladder tumours, with special reference to mitotic frequency. Int J Cancer 1992; 51: 396-403.
21. Lipponen PK. Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int J Cancer 1993; 53: 365-370.
22. Lipponen P. Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer. Eur J Cancer 1993; 29A: 749-753
23. Lipponen P, Eskelinen M. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis Br J Cancer 1994; 69: 1120-1125.
24. Lee E, Desu M. A computer program for comparing k samples with right censored data. Comput Programs Biomed 1972; 2: 315-320
25. Cox DR. Regression models and life tables with discussion J R Stat Soc B 1972; 34: 187-220.
26. Augereau P, Cracia M, Mattei MG, et al. Cloning and sequencing of the 52 K cathepsin D cDNA of MCF-7 breast cancer cell lines and mapping on chromosome 11 Mol Endocrinol 1988, 2: 186-192
27. Capony F, Rougeot C, Montcourrier P, Cavailles V, Salazar G, Rochefort H Increased secietion. altered processing and glycosylation of procathepsin D in human mammary cancer cells. Cancer Res 1989; 49: 3904-3909.
28. Rochefort H, Capony F, Garcia M, et al. Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis? J Cell Biochem 1987; 35: 17-29.
29. Kane SE, Gottesman MM. The role of cathepsin L in malignant transformation. Semin Cancer Biol 1990, 1: 127-136
30. Pagano M, Capony F, Rochefort L. La pro-cathepsin D peut activier in vitro la pro-cathepsine B secretée par les cancers ovariens. C R Acad Sci (Paris) 1989; 3009: 7-12.
31. Okamoto H, Greenbaum LM. Kininogen substrates for trypsin and cathepsin D in human, rabbit and rat plasmas. Life Sci 1983; 32: 2007-2013
32. Charpin C, Devictor B, Bonnier P, et al. Cathepsin D immunocytochemical analysis in breast carcinomas, image analysis and correlation to prognostic factors. J Pathol 1993; 170: 463-470.
33. Spyratos F, Maudelonde T, Brouillet J-P, et al. Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet 1989, 8672: 1115-1118.
34. Lopez-Beltran A, Morales C, Reymundo C, Toro M. T-zone histiocytes and recurrence of papillary urothelial bladder carcinoma. Urol Int 1989; 44: 205-209